By Mark Melchionna
May 09, 2023 – Earlier this month, the US Department of Health and Human Services (HHS) Office of Inspector General (OIG) announced errors in Medicare reimbursement for some psychotherapy services, including those provided…
Continue Reading
By Mark Melchionna
May 08, 2023 – Led by Sen. Edward J. Markey (D-Mass.), a group of US senators have urged the Drug Enforcement Agency (DEA) to permanently establish telehealth flexibilities in prescribing buprenorphine for opioid…
Continue Reading
With the COVID-19 Public Health Emergency set to expire on May 11, the U.S. Drug Enforcement Agency says it will temporarily extend telemedicine flexibilities around prescription of certain controlled medications as it sifts through…
Continue Reading
The unprecedented expansion of telehealth and mental health care during the pandemic was a monumental shift for behavioral health care in more ways than one.
The flexibilities for behavioral health visits that resulted from the…
By Mark Melchionna
April 26, 2023 – Published in Health Affairs, a new viewpoint article emphasized the prevalence of opioid use disorder (OUD)-related deaths and how regulatory actions are needed to ensure access to virtual…
Continue Reading
The following is a guest article by Ashley Perry, MPH, Chief Strategy and Solutions Officer at Socially Determined
When Congress passed the Consolidated Appropriations Act of 2023, it decoupled the Public Health Emergency (PHE) from…
